ArticleOncotarget2017

Addition of 5-fluorouracil to docetaxel/cisplatin does not improve survival in locoregionally advanced nasopharyngeal carcinoma.

Wang Fangzheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.